John S. Montalbano, Director at AbCellera Biologics Inc. (ABCL), bought 60,000 shares at $2.34 ($140K) on 2025-03-06, disclosed to the SEC on 2025-03-07.
Open-market purchase of $140k ABCL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ABCL | BUY | 2025-11-26 | $179K | — | Filing → |
| ABCL | BUY | 2025-03-10 | $115K | — | Filing → |
| ABCL | BUY | 2023-11-08 | $137K | — | Filing → |